Press Registration Now Open for the EULAR 2026 Congress in London
en-GBde-DEes-ESfr-FR

Press Registration Now Open for the EULAR 2026 Congress in London


Uniting global leaders to shape the future of research and care in rheumatic and musculoskeletal diseases.

The European Alliance of Associations for Rheumatology (EULAR) is now accepting press registrations for its flagship event, the EULAR 2026 Congress, taking place from 3–6 June at the Excel London. This international gathering will spotlight the latest breakthroughs in rheumatic and musculoskeletal diseases (RMDs), bringing together top-tier scientists, clinicians, and healthcare professionals.

As a premier event in the field of rheumatology, this year’s Congress promises another bold scientific programme featuring new clinical data and updated treatment guidelines as well as emerging therapies, cutting-edge technologies and patient-centred approaches transforming the RMD landscape.
  • Rare Disease: focusing on advances in rare rheumatic conditions and underscoring the importance of tailored research and treatment strategies.
  • AI in Rheumatology: sessions will explore the growing role of artificial intelligence in the field, from predictive diagnostics to personalised care pathways.
  • Women’s Health: dedicated tracks will address sex and gender differences in RMDs, aiming at improving outcomes across lifespan.
  • Public Health: showcasing different perspectives, emphasising prevention, equity, and global strategies to reduce the burden of RMDs.
What’s new for delegates
  • Bring Your Own Device (BYOD): to continue making an impact to sustainability and increase accessibility, attendees can use their own devices to explore poster sessions and Meet the EULAR Expert sessions.
  • Expanded Access:
    • Young Rheumatologists: a new registration category supports professionals being in their first three years of practice.
    • Global Inclusion: delegates residing in low- and low/middle income countries receive a 50% reduction on registration fees.
Additionally, the programme has further been adjusted to better accommodate delegate requests. Abstract and Case Report Submissions are open since 1 October 2025.

“We warmly welcome the media to join us in London as we highlight the global momentum in rheumatic and musculoskeletal diseases”, said Prof Xenofon Baraliakos, EULAR President. “Your coverage helps ensure that the latest research, technologies and treatment advances reach communities, patients and clinicians around the world”.

Exclusive media opportunities
Members of the press are invited to attend the official EULAR press conference on 4 June 2026 to learn more about recent breakthroughs and upcoming challenges in RMD research and care as well as to benefit from one-on-one interview access with expert panellists.

Press credentials and info
To apply for media accreditation or explore the Congress programme, visit: EULAR 2026 - Press Registration

We look forward to welcoming you to London for an inspiring and impactful EULAR 2026 Congress.

About EULAR
EULAR is the European umbrella organisation representing scientific societies, health professional associations and organisations for people with RMDs. EULAR aims to reduce the impact of RMDs on individuals and society, as well as improve RMD treatments, prevention, and rehabilitation. To this end, EULAR fosters excellence in rheumatology education and research, promotes the translation of research advances into daily care, and advocates for the recognition of the needs of those living with RMDs by EU institutions.

Contact
EULAR Communications, communications@eular.org

Regions: Europe, Switzerland
Keywords: Health, Medical

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonials

For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.
All of my work trips have been planned around stories that I've found on this site.
The under embargo section allows us to plan ahead and the news releases enable us to find key experts.
Going through the tailored daily updates is the best way to start the day. It's such a critical service for me and many of my colleagues.
Koula Bouloukos, Senior manager, Editorial & Production Underknown
We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet

We Work Closely With...


  • e
  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2025 by AlphaGalileo Terms Of Use Privacy Statement